• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,498.02 25.57
(0.24%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.9559391
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
33.95
103958.87
EPS(TTM)
Face Value()
Div & Yield %
36.69
1
0.64
 

moil ltd
RPSG Ventures reports consolidated net loss of Rs 57.50 crore in the March 2026 quarter
May 21,2026
Net Loss of RPSG Ventures reported to Rs 57.50 crore in the quarter ended March 2026 as against net loss of Rs 13.11 crore during the previous quarter ended March 2025. Sales rose 15.18% to Rs 2927.03 crore in the quarter ended March 2026 as against Rs 2541.26 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 137.98 crore in the year ended March 2026 as against net loss of Rs 49.04 crore during the previous year ended March 2025. Sales rose 17.85% to Rs 11323.10 crore in the year ended March 2026 as against Rs 9608.35 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2927.032541.26 15 11323.109608.35 18
OPM %12.5513.17 -14.1814.29 -
PBDT189.20201.04 -6 863.74735.42 17
PBT59.5998.14 -39 376.79365.43 3
NP-57.50-13.11 -339 -137.98-49.04 -181